Luzia M. Mayr
Strasbourg, 67000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: May 22, 2023
Distinct antibody profiles in HLA-B∗57+, HLA-B∗57- HIV controllers and chronic progressors.
Journal: AIDS (London, England)
Published: September 28, 2021
A FcɣRIIa polymorphism has a HLA-B57 and HLA-B27 independent effect on HIV disease outcome.
Journal: Genes and immunity
Published: March 25, 2020
Immune Correlates of Disease Progression in Linked HIV-1 Infection.
Journal: Frontiers in immunology
Published: February 21, 2019
Anti-V2 antibody deficiency in individuals infected with HIV-1 in Cameroon.
Journal: Virology
Published: November 07, 2018
HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies.
Journal: AIDS (London, England)
Published: April 24, 2018
Non-Neutralizing Antibodies Directed against HIV and Their Functions.
Journal: Frontiers in immunology
Published: August 31, 2017
Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity.
Journal: Scientific reports
Published: June 09, 2017
Role of nonneutralizing antibodies in vaccines and/or HIV infected individuals.
Journal: Current opinion in HIV and AIDS
Published: April 20, 2017
Langerhans Cells: the 'Yin and Yang' of HIV Restriction and Transmission.
Journal: Trends in microbiology
Published: January 25, 2017
Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.
Journal: PloS one
Published: January 03, 2017
Last Updated: 09/26/2026